Predictors of ICS/LABA prescribing in COPD patients: a study from general practice.
about
Long-acting muscarinic antagonist plus long-acting beta agonist versus long-acting beta agonist plus inhaled corticosteroid for stable chronic obstructive pulmonary diseaseMultimorbidity and Patient Safety Incidents in Primary Care: A Systematic Review and Meta-AnalysisLong-acting muscarinic antagonist + long-acting beta agonist versus long-acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta-analysisLong-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).Using Big Data to Assess Prescribing Patterns in Greece: The Case of Chronic Obstructive Pulmonary Disease.An observation of prescription behaviors and adherence to guidelines in patients with COPD: real world data from October 2012 to September 2014.Use of concomitant inhaled corticosteroids: pooled data from two phase III studies of aclidinium plus formoterol in COPD.A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications.The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study).Impact of lung function on exacerbations, health care utilization, and costs among patients with COPDFirst maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis.Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational.Does Cardiovascular Comorbidity Influence the Prescribing of Bronchodilators in Chronic Obstructive Pulmonary Disease?Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain).
P2860
Q24186227-583963AE-63CB-4386-B5E7-2B08EA9287FFQ26796372-808912B5-EBF6-4D61-A7B9-19A30E2C7E9DQ26800134-6F561C00-E6BA-418B-9D2F-D929C54575EAQ30238494-19A33F4A-7D32-48BB-916D-CE66E4C564ECQ31097021-3D8617F8-6AF2-42F4-81B5-15D60729DDBAQ31100125-725B7D25-5C36-4FEF-8BB6-D767F4210622Q31165976-F6F4E63F-2396-4287-9B9F-96743A0D6568Q33736509-F592FE57-594B-485E-AFB4-EE6476D028A8Q36557670-0D51010A-77F8-4EE7-AEF6-AFEF4163F674Q37142609-A4645E81-2EFA-46F2-AB0F-CA26DE913476Q37390146-341A510C-7423-4A4C-B59A-868B68729DA0Q37732345-072F7EF9-5F72-4AA3-97D6-0856F6BF3E19Q38749254-B7ECE51E-8638-4BD7-86C1-A3D622D6C222Q39420903-DF6FD02B-E5C1-4C2B-A65B-B5E7668553EF
P2860
Predictors of ICS/LABA prescribing in COPD patients: a study from general practice.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Predictors of ICS/LABA prescribing in COPD patients: a study from general practice.
@ast
Predictors of ICS/LABA prescribing in COPD patients: a study from general practice.
@en
type
label
Predictors of ICS/LABA prescribing in COPD patients: a study from general practice.
@ast
Predictors of ICS/LABA prescribing in COPD patients: a study from general practice.
@en
prefLabel
Predictors of ICS/LABA prescribing in COPD patients: a study from general practice.
@ast
Predictors of ICS/LABA prescribing in COPD patients: a study from general practice.
@en
P2860
P356
P1433
P1476
Predictors of ICS/LABA prescribing in COPD patients: a study from general practice.
@en
P2093
Anders Ostrem
Elin Drivenes
P2860
P2888
P356
10.1186/1471-2296-15-42
P50
P577
2014-03-05T00:00:00Z
P5875
P6179
1010720483